Landmark Study Reveals that Lung Cancer 10-Year Survival Dramatically Improves with Annual CT Screen

Landmark Study Reveals that Lung Cancer 10-Year Survival Dramatically Improves with Annual CT Screening and Prompt Treatment

SEATTLE, Oct. 25, 2006 at 2 p.m. Pacific Time – Lung cancer can be detected at its very earliest stage in 85 percent of patients using annual low-dose CT screening, and when followed by prompt surgical removal the 10-year survival rate is 92 percent. These results, to be reported in the October 26 New England Journal of Medicine, would dramatically decrease the number of deaths from lung cancer – the number-one cause of cancer deaths among both men and women in the United States.

The International Early Lung Cancer Action Project (I-ELCAP) study – which is the largest, long-term study to determine the usefulness of annual screening by CT – was launched by a team of researchers at New York-Presbyterian Hospital/Weill Cornell Medical Center in 1993 and has since expanded into an international collaboration of 38 institutions in seven countries. Swedish Medical Center is the only participating site in the entire Pacific Northwest.

Stage-I lung cancer is the only stage at which cure by surgery is highly likely. While survival rates have been climbing for other forms of cancer, the survival rates for lung cancer have remained dismal. Approximately 95 percent of the 173,000 people diagnosed each year die from the disease – more than breast, prostate and colon cancer combined. The high death rates are a consequence of lung cancer not being detected early enough for treatment to be curative.

Among the 31,567 people in the study, CT screening detected 484 people who were diagnosed with lung cancer, 412 of these were Stage-I. Of the Stage-I patients who chose not to be treated, all died within five years. Overall, the estimated 10-year survival rate for the 484 participants with lung cancer was 80 percent. The participants were 40 years of age and older and at risk for lung cancer because of a history of cigarette smoking, occupational exposure (to asbestos, beryllium, uranium or radon), or exposure to secondhand smoke.

“We believe this study provides compelling evidence that CT screening for lung cancer offers new hope for millions of people at risk for this disease and could dramatically reverse lung cancer death rates,” said thoracic surgeon Ralph W. Aye, M.D., principal investigator for the I-ELCAP study at Swedish Medical Center.

Since the early 1990s, there have been remarkable advances in CT scanners. Sub-millimeter ‘slicing’ can now be applied to the entire chest in a single breath-hold.

“Lung cancer may be detected when it is smaller than it was possible to diagnose previously,” said Kristin Manning, M.D., a sub-investigator of the I-ELCAP study at Swedish and radiologist with Seattle Radiologists. “Although CT scans once yielded only 30 images, current technology provides more than 600 images. As the technology advanced, the approaches for studying the usefulness of this technology have also advanced.”

The charge for a low-dose CT screening varies, but ranges from $200 to $300. Treatment for Stage-I lung cancer is less than half the cost of late-stage treatment. Estimates of the cost-effectiveness of CT screening for lung cancer are similar or better than those for mammography screening for breast cancer.

The current study was supported by numerous private and public grants, including a grant from the National Institutes of Health (NIH).

Members of the study’s writing committee were New York-Presbyterian/Weill Cornell’s Drs. David F. Yankelevitz (attending radiologist and professor of radiology and cardiothoracic surgery at Weill Cornell Medical College), Daniel Libby (attending pulmonologist and professor of pulmonary and critical-care medicine at Weill Cornell), James P. Smith (attending pulmonologist and professor of pulmonary and critical-care medicine), Mark Pasmantier (attending oncologist and professor of medicine), and Olli S. Miettinen (epidemiologist and professor of medicine).

For more information on the I-ELCAP study at Swedish Medical Center, call 206-292-7700.


About Swedish Medical Center

Swedish Medical Center is the largest, most comprehensive, nonprofit health provider in the Pacific Northwest. Founded in 1910, it now has more than 7,000 employees and a medical staff of more than 2,000 physicians, most of which are private practitioners. Swedish now encompasses three hospital campuses (First Hill, Providence and Ballard) totaling 1,245 licensed beds, a new community-based emergency room and specialty center in Issaquah, Swedish Home Care Services and Swedish Physicians – a network of 12 primary-care clinics located throughout the Greater Seattle area. In addition to general medical and surgical care, Swedish is known as a regional referral center, providing specialized treatment in areas such as cardiovascular care, cancer care, orthopedics, high-risk obstetrics, neurological care, sleep medicine, pediatrics, organ transplantation and clinical research. For more information, visit or call 1-800-SWEDISH (1-800-793-3474).

Blog post currently doesn't have any comments.
Leave comment

 Security code